Discontinuation report LABETALOL HYDROCHLORIDE INJECTION, USP
| Report ID | 245264 |
| Drug Identification Number | 02387468 |
| Brand name | LABETALOL HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | LABETALOL HYDROCHLORIDE INJECTION, USP |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | LABETALOL HYDROCHLORIDE |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 20ML 1VL |
| ATC code | C07AG |
| ATC description | BETA BLOCKING AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2023-01-10 |
| Remaining supply date | 2019-01-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | Discontinued 2023-01-10-The last lots and expiry dates are 760813/31-Jan-2018 - Reported in shortage ID 78454 |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-12-10 | French | Compare |
| v1 | 2024-12-10 | English | Compare |
Showing 1 to 2 of 2